These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4588820)

  • 1. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 3. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
    Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognosis of prostatic carcinoma.
    Mellinger GT
    Recent Results Cancer Res; 1977; (60):61-72. PubMed ID: 866797
    [No Abstract]   [Full Text] [Related]  

  • 6. Ureteral obstruction from prostatic carcinoma: response to endocrine and radiation therapy.
    Michigan S; Catalona WJ
    J Urol; 1977 Nov; 118(5):733-8. PubMed ID: 916091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.
    Ishibe T; Usui T; Nihira H
    J Urol; 1974 Aug; 112(2):237-40. PubMed ID: 4843340
    [No Abstract]   [Full Text] [Related]  

  • 8. Ureteral obstruction in the patient with prostatic carcinoma.
    Marks LS; Gallo DA
    Br J Urol; 1972 Aug; 44(4):411-6. PubMed ID: 5070145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent carcinoma of the prostate--why the controversy?
    Correa RJ; Anderson RG; Gibbons RP; Mason JT
    J Urol; 1974 May; 111(5):644-6. PubMed ID: 4823973
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of estrogen therapy for prostatic carcinoma.
    Blackard CE; Mellinger GT
    Postgrad Med; 1972 Mar; 51(3):140-5. PubMed ID: 4553219
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual remission of prostatic carcinoma with pulmonary metastases.
    Stenberg CC; Bunts RC
    J Urol; 1969 Aug; 102(2):236-9. PubMed ID: 5796902
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
    Gleason DF; Mellinger GT;
    J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of carcinoma of prostate, associated with bilateral ureteral obstruction.
    Khan AU; Utz DC
    J Urol; 1975 Jun; 113(6):816-9. PubMed ID: 1152155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic carcinoma: treatment of liver metastases with intravenous diethylstilbestrol diphosphate.
    Jacobo E; Flocks RH; Culp DA
    Urology; 1975 Sep; 6(3):351-3. PubMed ID: 1162814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinoma of the prostate: treatment comparisons.
    J Urol; 1967 Oct; 98(4):516-22. PubMed ID: 4862213
    [No Abstract]   [Full Text] [Related]  

  • 19. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP; Slack NH
    Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal therapy of prostatic carcinoma: is there a rationale for delayed treatment?
    Grossman HB
    Urology; 1986 Mar; 27(3):199-204. PubMed ID: 3513424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.